borderline significancep = 0.08
On the other hand, three studies using Dex monotherapy (only one course of Dex; additional courses of Dex were administered only to nonresponders) 8 9 10 showed inferior SR incidence compared with that of PSL with borderline significance ( N = 437; RR, 0.80; 95% CI, 0.62–1.03; p = 0.08; Fig. 1b ).